To assess the effectiveness and safety of sirolimus-eluting stents (SES) in de novo native coronary lesions in small vessels (</= 2.5 mm).
METHODS AND RESULTS
PORTO was a multicentre, prospective registry, performed in 274 patients. Of these, 120 (43.8%) patients were diabetic. A total of 324 lesions were treated with 347 SES. The primary end-point… (More)